Florida Medical Cannabis Patients Use It Primarily for Anxiety, Pain, and Depression, With Most Reporting Improvement
In a survey of 632 Florida medical cannabis patients, the top reasons for use were anxiety (61%), chronic pain (44%), and depression (40%), with 95-98% reporting improvement in these conditions, though many used it for reasons beyond their qualifying conditions.
Quick Facts
What This Study Found
Top qualifying conditions: PTSD (29.6%), "comparable conditions" (22.2%), chronic pain (25.6%). Top self-reported reasons: anxiety (60.6%), chronic pain (44.0%), depression (39.9%), PTSD (34.8%). Most reported improvement: anxiety (95.3%), depression (97.2%), chronic pain (98.4%), insomnia (86.4%), PTSD (91.5%). ADHD had lowest perceived improvement (66.7%). A notable proportion sought MC for conditions beyond officially qualifying ones.
Key Numbers
632 patients; 62.7% female; median age 45; anxiety 60.6% reason for use; chronic pain 44.0%; depression 39.9%; 95-98% improvement for top conditions; ADHD 66.7% improvement; blood pressure 57.4% unsure/no change.
How They Did This
Cross-sectional survey of 632 medical cannabis patients from 9 Florida MC clinics in 2022, assessing qualifying conditions, self-reported reasons for use, and perceived impacts.
Why This Research Matters
This study reveals a significant gap between what medical cannabis patients are officially certified for and what they are actually treating. The high self-reported improvement rates, including for conditions with limited evidence, highlight the need for clinical trials to validate or challenge patient experiences.
The Bigger Picture
Medical cannabis programs are designed around qualifying conditions, but patients are using cannabis for a broader range of symptoms. The disconnect between regulatory frameworks and patient behavior suggests either conditions lists need updating or patient expectations need better management.
What This Study Doesn't Tell Us
Convenience sample from 9 clinics may not represent all Florida patients. Self-reported outcomes susceptible to placebo effect and expectancy bias. No control group or objective outcome measures. 2022 data.
Questions This Raises
- ?Do the high self-reported improvement rates hold up in placebo-controlled trials?
- ?Should qualifying condition lists be expanded to match actual patient use patterns?
Trust & Context
- Key Stat:
- 95-98% reported improvement for anxiety, depression, and chronic pain
- Evidence Grade:
- Large convenience sample with comprehensive survey, limited by self-report bias and no control group.
- Study Age:
- 2024 publication with 2022 data
- Original Title:
- Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey.
- Published In:
- Medical cannabis and cannabinoids, 7(1), 138-148 (2024)
- Authors:
- Sajdeya, Ruba(3), Jugl, Sebastian(3), Wang, Yan(20), Perez, Juan G, Maloney, Sophie, Lopez-Quintero, Catalina, Goodin, Amie J, Winterstein, Almut G, Cook, Robert L
- Database ID:
- RTHC-05681
Evidence Hierarchy
Frequently Asked Questions
What do medical cannabis patients use it for?
In this Florida survey, the top reasons were anxiety (61%), chronic pain (44%), depression (40%), and PTSD (35%). Many patients used cannabis for conditions beyond their official qualifying diagnosis.
Do medical cannabis patients think it works?
Self-reported improvement rates were very high: 98% for chronic pain, 97% for depression, 95% for anxiety, and 91% for PTSD. However, these are subjective reports without placebo controls, so the true therapeutic effect is unknown.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05681APA
Sajdeya, Ruba; Jugl, Sebastian; Wang, Yan; Perez, Juan G; Maloney, Sophie; Lopez-Quintero, Catalina; Goodin, Amie J; Winterstein, Almut G; Cook, Robert L. (2024). Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey.. Medical cannabis and cannabinoids, 7(1), 138-148. https://doi.org/10.1159/000540593
MLA
Sajdeya, Ruba, et al. "Reasons for Use and Perceived Effects of Medical Cannabis: A Cross-Sectional Statewide Survey.." Medical cannabis and cannabinoids, 2024. https://doi.org/10.1159/000540593
RethinkTHC
RethinkTHC Research Database. "Reasons for Use and Perceived Effects of Medical Cannabis: A..." RTHC-05681. Retrieved from https://rethinkthc.com/research/sajdeya-2024-reasons-for-use-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.